Department of Pulmonary and Critical Care Medicine, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, 430014, Hubei, China.
Wuhan Centers for Disease Control and Prevention, Wuhan, 430024, Hubei, China.
BMC Infect Dis. 2023 Sep 27;23(1):632. doi: 10.1186/s12879-023-08594-1.
Influenza is a common illness for its high rates of morbidity and transmission. The implementation of non-pharmaceutical interventions (NPIs) during the COVID-19 pandemic to manage its dissemination could affect the transmission of influenza.
A retrospective analysis, between 2018 and 2023, was conducted to examine the incidence of influenza virus types A and B among patients in sentinel cities located in North or South China as well as in Wuhan City. For validations, data on the total count of influenza patients from 2018 to 2023 were collected at the Central Hospital of Wuhan, which is not included in the sentinel hospital network. Time series methods were utilized to examine seasonal patterns and to forecast future influenza trends.
Northern and southern cities in China had earlier outbreaks during the NPIs period by about 8 weeks compared to the 2018-2019. The implementation of NPIs significantly reduced the influenza-like illness (ILI) rate and infection durations. Influenza B Victoria and H3N2 were the first circulating strains detected after the relaxation of NPIs, followed by H1N1 across mainland China. The SARIMA model predicted synchronized H1N1 outbreak cycles in North and South China, with H3N2 expected to occur in the summer in southern cities and in the winter in northern cities over the next 3 years. The ILI burden is expected to rise in both North and South China over the next 3 years, with higher ILI% levels in southern cities throughout the year, especially in winter, and in northern cities mainly during winter. In Wuhan City and the Central Hospital of Wuhan, influenza levels are projected to peak in the winter of 2024, with 2 smaller peaks expected during the summer of 2023.
In this study, we report the impact of NPIs on future influenza trends in mainland China. We recommend that local governments encourage vaccination during the transition period between summer and winter to mitigate economic losses and mortality associated with influenza.
流感发病率和传播率高,是一种常见疾病。为管理其传播而在 COVID-19 大流行期间实施的非药物干预(NPIs)可能会影响流感的传播。
对 2018 年至 2023 年间中国北方和南方城市以及武汉市哨点城市的 A 型和 B 型流感病毒发病率进行回顾性分析。为了验证,收集了武汉市中心医院 2018 年至 2023 年期间流感患者总数的数据,但该医院未纳入哨点医院网络。利用时间序列方法检查季节性模式并预测未来流感趋势。
与 2018-2019 年相比,NPIs 期间中国北方和南方城市的疫情爆发时间提前了约 8 周。NPIs 的实施显著降低了流感样疾病(ILI)发生率和感染持续时间。流感 B 型 Victoria 和 H3N2 是 NPIs 放松后首次检测到的循环毒株,随后 H1N1 在中国大陆各地传播。SARIMA 模型预测,未来 3 年内,中国北方和南方地区的 H1N1 爆发周期将同步,南方城市夏季将出现 H3N2,北方城市冬季将出现 H3N2。未来 3 年内,中国北方和南方的 ILI 负担预计将增加,南方城市全年 ILI%水平较高,尤其是冬季,北方城市主要在冬季。在武汉市和武汉市中心医院,流感水平预计将在 2024 年冬季达到峰值,预计 2023 年夏季将出现 2 个较小的峰值。
在这项研究中,我们报告了 NPIs 对中国内地未来流感趋势的影响。我们建议地方政府在夏季和冬季过渡期间鼓励接种疫苗,以减轻与流感相关的经济损失和死亡率。